Alexandria Venture Investments Portfolio Companies

Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.

Thryv Therapeutics is a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.

Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.

Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.

Ozette Technologies is a life science data company that accelerates the development of therapies and diagnostics by digitizing immune data.

Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.

Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria.

DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.

AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.

Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention.

Marvin is made to empower caregivers, leading the global transformation to a modern and sustainable healthcare system.

Autoimmunity BioSolutions develops a future immuno-corrective treatment that restores healthy immune function.

CREATE Medicines is a biotech company developing in vivo CAR therapies using mRNA-LNP immune cell programming technology.

MOMA Therapeutics operates as a biotechnology company.

Kytopen develops genome engineering platforms that enable cell therapy research and manufacturing.

Fathom Therapeutics focuses on drug design by harnessing biomolecular motion to develop therapeutics that can reprogram protein function.

Pheast Therapeutics develops checkpoint therapies to harness the innate immune system.

Neomorph develops protein degradation therapies targeting diseases not addressed by conventional treatments.

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.

Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.

Vesigen Therapeutics is a biotechnology company that develops groundbreaking therapeutic products.

IgGenix is a biotechnology company.

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

Acrigen Biosciences is dedicated to making gene editing safe.